Annual Shareholders Equity
$5.47 M
+$22.68 M+131.77%
December 31, 2023
Summary
- As of February 10, 2025, AGE annual stockholders equity is $5.47 million, with the most recent change of +$22.68 million (+131.77%) on December 31, 2023.
- During the last 3 years, AGE annual shareholders equity has risen by +$10.59 million (+206.90%).
Performance
AGE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$5.47 M
+$33.01 M+119.86%
December 31, 2023
Summary
- As of February 10, 2025, AGE quarterly stockholders equity is $5.47 million, with the most recent change of +$33.01 million (+119.86%) on December 31, 2023.
- Over the past year, AGE quarterly shareholders equity has increased by +$22.68 million (+131.77%).
Performance
AGE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AGE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +131.8% | +131.8% |
| 3 y3 years | +206.9% | +206.9% |
| 5 y5 years | -26.6% | -26.6% |
AGE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -414.7% | at high | -603.5% |
| 5 y | 5-year | at high | -414.7% | at high | -603.5% |
| alltime | all time | -26.6% | -414.7% | -41.3% | -603.5% |
AgeX Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $5.47 M(-131.8%) | $5.47 M(-119.9%) |
| Sep 2023 | - | -$27.54 M(+24.2%) |
| Jun 2023 | - | -$22.18 M(+11.5%) |
| Mar 2023 | - | -$19.89 M(+15.6%) |
| Dec 2022 | -$17.21 M(+45.5%) | -$17.21 M(+14.0%) |
| Sep 2022 | - | -$15.10 M(+14.3%) |
| Jun 2022 | - | -$13.22 M(+14.5%) |
| Mar 2022 | - | -$11.55 M(-2.4%) |
| Dec 2021 | -$11.83 M | -$11.83 M(+19.1%) |
| Sep 2021 | - | -$9.94 M(+20.4%) |
| Jun 2021 | - | -$8.25 M(+36.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -$6.06 M(+18.5%) |
| Dec 2020 | -$5.12 M(-330.7%) | -$5.12 M(+40.1%) |
| Sep 2020 | - | -$3.65 M(+49.4%) |
| Jun 2020 | - | -$2.44 M(+230.7%) |
| Mar 2020 | - | -$739.00 K(-133.3%) |
| Dec 2019 | $2.22 M(-70.2%) | $2.22 M(-48.9%) |
| Sep 2019 | - | $4.34 M(-35.7%) |
| Jun 2019 | - | $6.75 M(-27.6%) |
| Mar 2019 | - | $9.32 M(+25.2%) |
| Dec 2018 | $7.45 M(+2.3%) | $7.45 M |
| Dec 2017 | $7.28 M | - |
FAQ
- What is AgeX Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for AgeX Therapeutics?
- What is AgeX Therapeutics annual shareholders equity year-on-year change?
- What is AgeX Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for AgeX Therapeutics?
- What is AgeX Therapeutics quarterly shareholders equity year-on-year change?
What is AgeX Therapeutics annual stockholders equity?
The current annual shareholders equity of AGE is $5.47 M
What is the all time high annual shareholders equity for AgeX Therapeutics?
AgeX Therapeutics all-time high annual stockholders equity is $7.45 M
What is AgeX Therapeutics annual shareholders equity year-on-year change?
Over the past year, AGE annual stockholders equity has changed by +$22.68 M (+131.77%)
What is AgeX Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of AGE is $5.47 M
What is the all time high quarterly shareholders equity for AgeX Therapeutics?
AgeX Therapeutics all-time high quarterly stockholders equity is $9.32 M
What is AgeX Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, AGE quarterly stockholders equity has changed by +$22.68 M (+131.77%)